We announce our participation in Rescon USA Summit 2023 (28-29 September, 2023, Manhattan, New York), the prestigious conference about inhalation & connected devices
RESCON SUMMIT highlights innovations in the respiratory sector and connected devices. The event will showcase new trends in aerosol science and the future directions of inhalation drug delivery research.
This event will bring together key industry experts and thought leaders to discuss the latest trends in Sustainable Inhalation devices, Inhaled mRNA Therapy, and other cutting-edge technologies to overcome lung and pulmonary conditions such as COPD, asthma and cystic fibrosis. With over 25 sessions, attendees will also gain insights on on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices.
The event will also cover a range of practical topics, including Digital health combination products, Analytical tools for inhaled medicines, Market challenges in inhalation and respiratory drug delivery, Regulatory updates in the global respiratory market, Inhaled drugs through FRI and artificial intelligence AI, Artificial Intelligence in Inhalation Medical Devices, Smart Inhalers and Medical Device Design Strategy.
The event will be held in a special venue, providing ample opportunities for networking and forging connections with peers in the industry. There will be about 100 attendees from leading pharmaceutical and biotechnology companies, including Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments.
Click here for more detailed information.